Table 2.
Association between lncRNA BLACAT1 expression and clinicopathological traits in PTC patients
| Parameters | lncRNA BLACAT1 | χ2 | P | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| (n = 44) | (n = 43) | |||
| Gender | ||||
| Male | 15 (34.09) | 7 (16.28) | 5.122 | 0.029* |
| Female | 29 (65.91) | 36 (83.72) | ||
| Age (years) | ||||
| < 45 | 20 (46.94) | 25 (58.14) | 1.825 | 0.317 |
| ≥ 45 | 24 (53.06) | 18 (41.86) | ||
| Extrathyroidal extension | ||||
| Positive | 24 (54.55) | 20 (46.51) | 0.716 | 0.581 |
| Negative | 20 (45.45) | 23 (53.49) | ||
| Tumor size (cm) | ||||
| ≤ 1 | 28 (63.64) | 32 (74.42) | 1.105 | 0.426 |
| > 1 | 16 (36.36) | 11 (25.58) | ||
| TNM staging | ||||
| I/II | 32 (72.73) | 36 (83.72) | 3.226 | 0.204 |
| III/IV | 12 (27.27) | 7 (16.28) | ||
| Lymph node metastasis | ||||
| Positive | 14 (31.82) | 27 (62.79) | 9.718 | 0.001* |
| Negative | 30 (68.18) | 16 (37.21) | ||
| Nodular goiter | ||||
| Positive | 25 (56.82) | 19 (44.19) | 3.863 | 0.077 |
| Negative | 19 (43.18) | 24 (55.81) | ||
| Multifocality | ||||
| Positive | 13 (29.55) | 14 (33.56) | 0.034 | 1.000 |
| Negative | 31 (70.45) | 29 (67.44) | ||
| Hashimoto thyroiditis | ||||
| Positive | 7 (15.91) | 8 (18.60) | 0.091 | 0.804 |
| Negative | 37 (84.09) | 35 (81.40) | ||
* P < 0 05, Chi squared test P value